David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GG
1726
PUT
DELISTED
Goldcorp Inc
GG
| $3.6M | ﹤0.01% |
262,300
-35,000
| -12% | -$486K |
|
1727
Hawaiian Electric Industries
HE
$1.96B
| $3.59M | ﹤0.01% |
+104,649
| New | +$3.56M |
|
1728
Daktronics
DAKT
$923M
| $3.58M | ﹤0.01% |
420,243
+53,594
| +15% | +$480K |
|
1729
TTM Technologies
TTMI
$11.8B
| $3.57M | ﹤0.01% |
202,702
+98,662
| +95% | +$1.65M |
|
1730
PUT
Elevance Health
ELV
$86.5B
| $3.57M | ﹤0.01% |
15,000
-4,500
| -23% | -$1.04M |
|
|
NVRO
1731
DELISTED
NEVRO CORP.
NVRO
| $3.57M | ﹤0.01% |
44,693
+40,521
| +971% | +$3.36M |
|
1732
CALL
General Mills
GIS
$21.3B
| $3.57M | ﹤0.01% |
+80,600
| New | +$3.53M |
|
|
COHR
1733
DELISTED
Coherent Inc
COHR
| $3.56M | ﹤0.01% |
22,794
+13,431
| +143% | +$2.28M |
|
1734
PUT
McKesson
MCK
$106B
| $3.56M | ﹤0.01% |
26,700
-4,700
| -15% | -$687K |
|
1735
Larimar Therapeutics
LRMR
$432M
| $3.56M | ﹤0.01% |
29,013
-3,779
| -12% | -$321K |
|
1736
CALL
Core Laboratories
CLB
$553M
| $3.56M | ﹤0.01% |
+28,200
| New | +$3.43M |
|
1737
CALL
Palo Alto Networks
PANW
$277B
| $3.56M | ﹤0.01% |
103,800
+59,400
| +134% | +$1.98M |
|
1738
CALL
Factset
FDS
$10.5B
| $3.55M | ﹤0.01% |
17,900
+1,900
| +12% | +$380K |
|
1739
CALL
Vale
VALE
$65.2B
| $3.55M | ﹤0.01% |
276,600
-345,000
| -56% | -$4.71M |
|
|
HDP
1740
DELISTED
Hortonworks, Inc.
HDP
| $3.54M | ﹤0.01% |
194,584
-156,381
| -45% | -$2.81M |
|
1741
Hershey
HSY
$37.6B
| $3.53M | ﹤0.01% |
+37,950
| New | +$3.54M |
|
|
SUP
1742
DELISTED
Superior Industries International
SUP
| $3.53M | ﹤0.01% |
197,234
+85,973
| +77% | +$1.41M |
|
1743
Devon Energy
DVN
$51.6B
| $3.53M | ﹤0.01% |
80,201
-4,487,982
| -98% | -$174M |
|
1744
Apogee Enterprises
APOG
$861M
| $3.51M | ﹤0.01% |
+72,809
| New | +$3.13M |
|
1745
Magnite
MGNI
$3.43B
| $3.5M | ﹤0.01% |
1,228,114
-216,025
| -15% | -$514K |
|
1746
PetMed Express
PETS
$38.2M
| $3.5M | ﹤0.01% |
79,373
+49,252
| +164% | +$1.91M |
|
|
RSPP
1747
DELISTED
RSP Permian, Inc.
RSPP
| $3.5M | ﹤0.01% |
79,416
-221,821
| -74% | -$10M |
|
1748
CALL
WEX
WEX
$6.81B
| $3.49M | ﹤0.01% |
18,300
+11,100
| +154% | +$1.94M |
|
|
PDM
1749
Piedmont Realty Trust
PDM
$1.24B
| $3.48M | ﹤0.01% |
174,560
-147,133
| -46% | -$2.73M |
|
1750
CALL
Under Armour
UAA
$2.2B
| $3.48M | ﹤0.01% |
154,700
+99,700
| +181% | +$1.97M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.